Alpha Centric Advisors LLC Aurinia Pharmaceuticals Inc. Transaction History
Alpha Centric Advisors LLC
- $121 Million
- Q2 2024
A detailed history of Alpha Centric Advisors LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 80,000 shares of AUPH stock, worth $561,600. This represents 0.38% of its overall portfolio holdings.
Number of Shares
80,000
Previous 80,000
-0.0%
Holding current value
$561,600
Previous $400,000
14.0%
% of portfolio
0.38%
Previous 0.28%
Shares
10 transactions
Others Institutions Holding AUPH
# of Institutions
191Shares Held
56.7MCall Options Held
499KPut Options Held
637K-
Armistice Capital, LLC New York, NY11.1MShares$78.2 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$65.1 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$27.9 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$20.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$19.5 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $996M
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...